Baby And Toddler BioNTech Jabs Arrive In Hong Kong
"); jQuery("#212 h3").html("

"); });
2022-11-05 HKT 00:18
The government on Friday said a batch of about 96,000 shots of the baby and toddler version of the BioNTech Covid vaccine had arrived in Hong Kong. Distributed here under the name Comirnaty, the vaccine is for children aged between six months and four years.
Last month, the government signed off on the use of the toddler version of the mRNA vaccine, after taking into account the views of experts on a government-appointed advisory panel.
Previously the BioNTech shot had only been given to those aged five and above, while the Sinovac inactivated virus jab was made available for younger children in August.
Government advisers had previously said that BioNTech was safe for infants, but that they would require a dose of around a tenth of that given to adults.
Manulife Names Wilton Kee As CEO For Hong Kong And Macau
Manulife has appointed Wilton Kee as the new Chief Executive Officer for its Hong Kong and Macau operations, effective ... Read more
Banks Are Not Ready For AI | Singapore AI CxO Roundtable
In this exclusive roundtable jointly hosted by Fintech News Network and Alteryx, senior banking leaders in Singapore sh... Read more
Mizuho Bank To Invest In Rakuten Bank In October
Mizuho Bank will shift its investment into a 5.81% stake in Rakuten Bank, according to Japan Today. The move allows the... Read more
Forthright Subsidiaries Secure SFC Approval For Virtual Asset Services Across 3 Licenses
Forthright Securities and Forthright Capital have received approval from the Securities and Futures Commission (SFC) to... Read more
SFC Names Elisa Ng To Lead Investment Products, Reappoints Lisa Chen
The Securities and Futures Commission (SFC) has appointed former J.P. Morgan Asset Management executive Elisa Ng as its... Read more
Mastercard And JD.com Partner To Expand Cross-Border Payment Options In China
Mastercard and JD.com have entered a strategic partnership to develop cross-border supply chain finance tools for busin... Read more
